U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07065032) titled 'A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM)' on June 06.
Brief Summary: This study will comprise a randomized, double blind, placebo controlled, multiple ascending dose, safety, tolerability and pharmacokinetic study of ZT002 in subjects with type 2 diabetes mellitus (T2DM).
Study Start Date: Feb. 19, 2024
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: ZT002 Injection
Q2W, subcutaneous injection
DRUG: ZT002 Injection
Q2W, subcutaneous injection
DRUG: ZT002 Placebo
Participants will receive the same volume as the study drug in each cohort.
Recruitmen...